Literature DB >> 1708281

Rapid nuclear accumulation of injected oligodeoxyribonucleotides.

D J Chin1, G A Green, G Zon, F C Szoka, R M Straubinger.   

Abstract

The intracellular transport and fate of nucleic acids is poorly understood. To study this process, we injected fluorescent oligodeoxyribonucleotides (oligos) into the cytoplasm of CV-1 epithelial cells and primary human fibroblasts. Rapid nuclear accumulation was found with the phosphodiester (PD), phosphorothioate (PT), and methylphosphonate (MP) forms of a 28-mer oligo complimentary to the rev mRNA of the human immunodeficiency virus type 1. Migration of the oligos in the cytoplasm was slower than diffusion of a coinjected dextran, but the oligos freely diffused into the nucleus. Nuclear incorporation was temperature but not energy dependent. The intranuclear distribution of the oligos was influenced by the chemistry of internucleoside linkages. The PD oligos and, to a lesser extent, the PT oligos colocalized with small nuclear ribonucleoproteins (snRNPs), whereas the MP oligos colocalized with concentrated regions of genomic DNA. These data have important implications for our understanding of the transport and accumulation of exogenous nucleic acids in mammalian nuclei, and the assay described could potentially be used for testing the efficacy of oligos designed as therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1708281

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  36 in total

1.  Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides.

Authors:  C Pichon; M B Roufaï; M Monsigny; P Midoux
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.

Authors:  P Lorenz; T Misteli; B F Baker; C F Bennett; D L Spector
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

3.  Delivery of oligonucleotides into mammalian cells by anionic peptides: comparison between monomeric and dimeric peptides.

Authors:  I Freulon; A C Roche; M Monsigny; R Mayer
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

4.  Linear 2' O-Methyl RNA probes for the visualization of RNA in living cells.

Authors:  C Molenaar; S A Marras; J C Slats; J C Truffert; M Lemaître; A K Raap; R W Dirks; H J Tanke
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

5.  Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.

Authors:  Philippe de Diesbach; Francisca N'Kuli; Catherine Berens; Etienne Sonveaux; Michel Monsigny; Annie-Claude Roche; Pierre J Courtoy
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

6.  Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.

Authors:  F Shi; A Nomden; V Oberle; J B Engberts; D Hoekstra
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

7.  Potent and selective gene inhibition using antisense oligodeoxynucleotides.

Authors:  W M Flanagan; R W Wagner
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

8.  Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter.

Authors:  Y K Oh; R M Straubinger
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

9.  Transcription on lampbrush chromosome loops in the absence of U2 snRNA.

Authors:  A Tsvetkov; M Jantsch; Z Wu; C Murphy; J G Gall
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

10.  Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

Authors:  C Beltinger; H U Saragovi; R M Smith; L LeSauteur; N Shah; L DeDionisio; L Christensen; A Raible; L Jarett; A M Gewirtz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.